أعرض في EDS

Panobinostat in combination with bortezomib and dexamethasone as induction therapy in patients with multiple myeloma, candidates for autologous transplant

التفاصيل البيبلوغرافية
العنوان: Panobinostat in combination with bortezomib and dexamethasone as induction therapy in patients with multiple myeloma, candidates for autologous transplant
المؤلفون: Maria Luisa La Targia, Roberto Cairoli, Lara Pochintesta, Erika Ravelli, Silvia Mangiacavalli, Lucia Farina, Luca Baldini, Virginia Valeria Ferretti, Vittorio Montefusco, Federica Cocito, Alessandro Corso
المساهمون: Mangiacavalli, S, Pochintesta, L, Ravelli, E, Baldini, L, Ferretti, V, La Targia, M, Farina, L, Cocito, F, Cairoli, R, Montefusco, V, Corso, A
بيانات النشر: Taylor & Francis, 2015.
سنة النشر: 2015
مصطلحات موضوعية: Oncology, Adult, Diarrhea, Cancer Research, medicine.medical_specialty, Neutropenia, Vomiting, Dexamethasone, Hydroxamic Acid, Bortezomib, chemistry.chemical_compound, Induction therapy, Internal medicine, Panobinostat, medicine, Multiple myeloma, Antineoplastic Combined Chemotherapy Protocol, business.industry, Nausea, Hematology, Induction Chemotherapy, Middle Aged, medicine.disease, Thrombocytopenia, Clinical trial, Transplantation, Transplantation, Autologou, surgical procedures, operative, Treatment Outcome, chemistry, Indole, Preoperative Period, Stem cell, business, Multiple Myeloma, medicine.drug, Human, Stem Cell Transplantation
الوصف: Autologous stem cell transplant (ASCT) is still considered an effective option for first-line treatment in transplant eligible young patients with multiple myeloma (MM), even in the era of novel ag...
وصف الملف: STAMPA
اللغة: English
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b18845918857067e6fefa43c2afda3a
https://hdl.handle.net/10281/408740
Rights: CLOSED
رقم الانضمام: edsair.doi.dedup.....6b18845918857067e6fefa43c2afda3a
قاعدة البيانات: OpenAIRE
الوصف
الوصف غير متاح.